Bringing Medicines for HIV Prevention to a Family Planning Clinic

The goal of this clinical trial is to understand what patients and physicians think about providing medications to prevent HIV transmission to patients in a family planning clinic. These medications are known as pre-exposure prophylaxis, or PrEP. The main questions to answer are: 1. Do patients find it acceptable to be asked about, and offered, PrEP during their visit to a family planning clinic? 2. What things make it easier or harder to ask about PrEP in a family planning clinic setting? 3. What things make it easier or harder to begin PrEP in a family planning clinic setting? Patient participants: 1. Will receive standardized counseling about PrEP. 2. Will have the opportunity to begin PrEP as part of their routine, ongoing care. 3. Will be asked to complete a survey about their experiences. Physician participants: 1. Will receive standardized education about PrEP. 2. Will talk to patient participants about PrEP, and support patient participants who want to begin PrEP. 3. Will be asked to complete pre-and post-study surveys about their experiences. 4. May be asked to complete a post-study in-depth interview about their experiences.

This study will include patient participants who: * Are age 16 or older * Are presenting for care at the Women and Infants Hospital of Rhode Island Family Planning Clinic * Speak English or Spanish * Have decisional capacity This study will exclude patient participants who: \- Are currently seeking abortion care This study will include physician participants who: \- Provide care at the Women and Infants Hospital of Rhode Island Family Planning Clinic This study will not have any specific exclusion criteria for physician participants.